111 related articles for article (PubMed ID: 3465673)
21. [Familial type III hyperlipoproteinemia].
Eto M; Saito M
Nihon Rinsho; 2013 Sep; 71(9):1590-4. PubMed ID: 24205719
[TBL] [Abstract][Full Text] [Related]
22. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
23. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
Nikkilä EA; Ylikahri R; Huttunen JK
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
[TBL] [Abstract][Full Text] [Related]
24. [Clinical research on the hypolipidemic action of a probucol preparation].
Naumova R; Kerekovska M; Goranov I; Balabanski L
Vutr Boles; 1986; 25(2):73-7. PubMed ID: 3716382
[TBL] [Abstract][Full Text] [Related]
25. Ratio of remnant-like particle-cholesterol to serum total triglycerides is an effective alternative to ultracentrifugal and electrophoretic methods in the diagnosis of familial type III hyperlipoproteinemia.
Wang T; Nakajima K; Leary ET; Warnick GR; Cohn JS; Hopkins PN; Wu LL; Cilla DD; Zhong J; Havel RJ
Clin Chem; 1999 Nov; 45(11):1981-7. PubMed ID: 10545069
[TBL] [Abstract][Full Text] [Related]
26. Comparative effects of gemfibrozil and clofibrate in type III hyperlipoproteinemia.
Larsen ML; Illingworth DR; O'Malley JP
Atherosclerosis; 1994 Apr; 106(2):235-40. PubMed ID: 8060383
[TBL] [Abstract][Full Text] [Related]
27. Treatment of type III hyperlipoproteinemia with four different treatment regimens.
Hoogwerf BJ; Bantle JP; Kuba K; Frantz ID; Hunninghake DB
Atherosclerosis; 1984; 51(2-3):251-9. PubMed ID: 6588975
[TBL] [Abstract][Full Text] [Related]
28. Effect of infusion of normal plasma on lipoproteins in type III hyperlipoproteinemia.
Stuyt PM; Demacker PN; van 't Laar A
Horm Metab Res; 1981 Dec; 13(12):715-6. PubMed ID: 7319472
[No Abstract] [Full Text] [Related]
29. Comparison of the hypolipidemic effect of gemfibrozil versus simvastatin in patients with type III hyperlipoproteinemia.
Civeira F; Cenarro A; Ferrando J; Puzo J; Garcia-Otín AL; Mozas P; Pocoví M
Am Heart J; 1999 Jul; 138(1 Pt 1):156-62. PubMed ID: 10385780
[TBL] [Abstract][Full Text] [Related]
30. Inheritance of type-III hyperlipoproteinemia. Lipoprotein patterns in first-degree relatives.
Vessby B; Hedstrand H; Lundin LG; Olsson U
Metabolism; 1977 Mar; 26(3):225-54. PubMed ID: 189159
[TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein EBethesda: a new variant of apolipoprotein E associated with type III hyperlipoproteinemia.
Gregg RE; Ghiselli G; Brewer HB
J Clin Endocrinol Metab; 1983 Nov; 57(5):969-74. PubMed ID: 6578216
[TBL] [Abstract][Full Text] [Related]
32. Dual defect in metabolism of very-low-density lipoprotein triglycerides. Patients with type 5 hyperlipoproteinemia.
Kesaniemi YA; Grundy SM
JAMA; 1984 May; 251(19):2542-7. PubMed ID: 6716583
[TBL] [Abstract][Full Text] [Related]
33. [Primary hyperlipoproteinemia type 3].
Watanabe A; Mabuchi H; Takeda R
Nihon Rinsho; 1983 Aug; 41(8):1804-9. PubMed ID: 6579323
[No Abstract] [Full Text] [Related]
34. Adipose tissue lipoprotein lipase activity in type III hyperlipoproteinemia.
Goldberg AP; Applebaum-Bowden DM; Hazzard WR
Metabolism; 1979 Nov; 28(11):1122-6. PubMed ID: 226832
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of the efficiency of gemfibrozil in treating hyperlipidemia type IIb and IV].
Polakowska M; Broda G; Rywik S; Piotrowski W; Bednarska M; Kuźmińska A; Pytlak A; Chotkowska E
Pol Arch Med Wewn; 1994 Jan; 91(1):9-18. PubMed ID: 8190659
[TBL] [Abstract][Full Text] [Related]
36. Effect of clofibrate and colestipol singly and in combination on plasma lipids and lipoproteins in type III hyperlipoproteinemia.
Hoogwerf BJ; Peters JR; Frantz ID; Hunninghake DB
Metabolism; 1985 Oct; 34(10):978-81. PubMed ID: 4046841
[TBL] [Abstract][Full Text] [Related]
37. Manganese-heparin precipitation of very low-density lipoprotein: screening for type III hyperlipoproteinaemia.
Muirhead RA; Dodd HE
Ann Clin Biochem; 1989 May; 26 ( Pt 3)():289-91. PubMed ID: 2764475
[No Abstract] [Full Text] [Related]
38. The hypolipidemic effects of lovastatin and clofibrate alone and in combination in patients with type III hyperlipoproteinemia.
Illingworth DR; O'Malley JP
Metabolism; 1990 Apr; 39(4):403-9. PubMed ID: 2182974
[TBL] [Abstract][Full Text] [Related]
39. Effects of statins on triglyceride metabolism.
Ginsberg HN
Am J Cardiol; 1998 Feb; 81(4A):32B-35B. PubMed ID: 9526811
[TBL] [Abstract][Full Text] [Related]
40. The independent synthesis of intermediate density lipoproteins in type III hyperlipoproteinemia.
Reardon MF; Poapst ME; Steiner G
Metabolism; 1982 May; 31(5):421-7. PubMed ID: 7078425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
